Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Best Practice & Research. Clinical Gastroenterology|April 19, 2005
Abdominal epilepsyNoah T Zinkin, Mark A PeppercornExpert Opinion on Drug Safety|March 21, 2007
The risks and the benefits of mesalazine as a treatment for ulcerative colitisAlan C Moss, Mark A PeppercornExpert Opinion on Drug Safety|April 10, 2010
Efficacy and safety of drugs for ulcerative colitisLaura Noddin Rosenberg, Mark A PeppercornPancreas|February 13, 2014
A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitisSaurabh Sethi, Nidhi Sethi, Vaibhav Wadhwa, et al.Drugs|November 23, 2006
Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to dateChandrashekhar Thukral, Adam Cheifetz, Mark A PeppercornCurrent Treatment Options in Gastroenterology|May 26, 2005
The Role of Antibiotics in Inflammatory Bowel DiseaseChandrashekhar Thukral, Win J Travassos, Mark A PeppercornDigestive Diseases and Sciences|October 16, 2007
Meta-analysis of the placebo response in ulcerative colitisSagar Garud, Alphonso Brown, Adam Cheifetz, et al.Therapeutic Advances in Gastroenterology|June 14, 2019
Insights into the treatment of inflammatory bowel disease in pregnancySarah E Shannahan, Jonathan M Erlich, Mark A PeppercornNature Clinical Practice. Gastroenterology & Hepatology|May 5, 2006
Combined oral and topical mesalazine treatment for extensive ulcerative colitisAlan C Moss, Adam S Cheifetz, Mark A PeppercornThe Journal of Antimicrobial Chemotherapy|March 6, 2007
Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanideDaniel M Musher, Nancy Logan, Vaibhav Mehendiratta, et al.Pageof 4